Tofacitinib citrate WhatsApp:+8618873306038

Tofacitinib citrate WhatsApp:+8618873306038

Just try a small order to start our cooperation, we will NOT make you down !
Any products interested pls let me know I will give info.in details.
[email protected]
Skype:live:kathelin_4
WhatsApp:+8618873306038

CAS No.540737-29-9
Chemical Name:Tofacitinib citrate
SynonymsXeljanz;CP 690500-10;CP 690550-10;Tofacitinib API;CP-690550 citrate;Tasocitinib citrate;Tofacitinib citrate;Tofacitinib Citratet;Tofacititinib cirate;Xeljanz(tofacitinib)
CBNumber:CB92460269
Molecular Formula:C16H20N6O.C6H8O7
Formula Weight:504.497
storage temp. room temp
solubility DMSO: soluble5mg/mL (clear solution; warmed)
color white to beige

Description
Tofacitinib citrate is a king of drugs developed by the US pharmaceutical company Pfizer for treating rheumatoid arthritis, trade name Xeljanz, for the treatment of methotrexate inadequate response or intolerance to severe active rheumatoid arthritis (RA) in adult patients. This product is a Janus kinase inhibitor, administered twice daily.
November 6, 2012, the US Food and Drug Administration (FDA) and Pfizer jointly announced Tofacitinib citrate is approved for the treatment of methotrexate inadequate response or intolerance to severe active rheumatoid joints arthritis (RA) in adult patients.
Xeljanz can be used as monotherapy or in combination with methotrexate or other non-biological disease-modifying antirheumatic drugs (the DMARD) in combination. This medicine should not be in combination with biological DMARD or strong immunosuppressants (such as cyclosporine and azathioprine). Xeljanz is approved by the daily dose of 2 times, each time 5mg.
Seven clinical trials evaluated the safety and efficacy of Tofacitinib citrate in moderate to severe active RA in adult patients. In all tests, compared with patients receiving placebo, patients receiving Xeljanz treatment showed significant improvement in clinical response and physical function.
In Clinical trials, the most common adverse events were upper respiratory tract infection, headache, diarrhea, nasal congestion, sore throat, and nasopharyngitis.